Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06029517 · ClinicalTrials.gov registry record · NA

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

A NA study of Coronary Artery Disease and Diabetes Mellitus, sponsored by Roswell Park Cancer Institute.

Active
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06029517: Active NA study of Coronary Artery Disease and Diabetes Mellitus, sponsored by Roswell Park Cancer Institute.

NCT06029517 is a NA study of Coronary Artery Disease and Diabetes Mellitus that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 48 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06029517, a NA study of Coronary Artery Disease and Diabetes Mellitus, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men

Primary Outcome

Change in Sugar Sweet Beverage (SSB) intake per day from baseline to 6 months follow-up for men affiliated with Native American athletic communities

Interventions

  • OTHER Education Intervention
  • OTHER Interview
  • PROCEDURE Discussion

Study Locations (1)

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2022-07-20
Est. Completion 2026-09-15
Phase NA
Roswell Park Cancer Institute

365 total trials

What the registry record for NCT06029517 still lists

NCT06029517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 3 interventions - of which Education Intervention is the first listed.

NCT06029517 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06029517 about?

NCT06029517 is a clinical study titled "A Sugar-Sweetened Beverage Reduction Intervention for Native American Men". This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may l...

What is the current status of trial NCT06029517?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-07-20. Estimated completion is 2026-09-15.

What conditions does trial NCT06029517 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Diabetes Mellitus, Obesity-Related Malignant Neoplasm, Cardiovascular Disorder.

What interventions are being tested in trial NCT06029517?

The interventions under investigation include: Education Intervention (OTHER), Interview (OTHER), Discussion (PROCEDURE).

Who is sponsoring clinical trial NCT06029517?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06029517 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06029517's enrollment target sits among peer trials

48 182nd of 219 higher than 36 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06029517, the US trial registry maintained by the National Library of Medicine. NCT06029517 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.